<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78587</article-id><article-id pub-id-type="doi">10.7554/eLife.78587</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-275860"><name><surname>Carrier</surname><given-names>Arnaud</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275861"><name><surname>Desjobert</surname><given-names>Cécile</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275862"><name><surname>Ponger</surname><given-names>Loic</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275863"><name><surname>Lamant</surname><given-names>Laurence</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275864"><name><surname>Bustos</surname><given-names>Matias</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275865"><name><surname>Torres-Ferreira</surname><given-names>Jorge</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275866"><name><surname>Henrique</surname><given-names>Rui</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141803"><name><surname>Jeronimo</surname><given-names>Carmen</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-271416"><name><surname>Lanfrancone</surname><given-names>Luisa</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275867"><name><surname>Delmas</surname><given-names>Audrey</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-54333"><name><surname>Favre</surname><given-names>Gilles</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275868"><name><surname>Delaunay</surname><given-names>Antoine</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275869"><name><surname>Busato</surname><given-names>Florence</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275870"><name><surname>Hoon</surname><given-names>Dave SB</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-168251"><name><surname>Tost</surname><given-names>Jorg</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275871"><name><surname>Etievant</surname><given-names>Chantal</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-275872"><name><surname>Riond</surname><given-names>Joëlle</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-251752"><name><surname>Arimondo</surname><given-names>Paola B</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5175-4396</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Unité de Service et de Recherche USR 3388</institution>, <institution>CNRS-Pierre Fabre</institution>, <addr-line><named-content content-type="city">Toulouse</named-content></addr-line>, <country>France</country></aff><aff id="aff2"><institution>CNRS UMR 7196, INSERM U1154</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff3"><institution content-type="dept">Cancer Research Center of Toulouse</institution>, <institution>UMR 1037, INSERM, Université Toulouse III Paul Sabatier</institution>, <addr-line><named-content content-type="city">Toulouse</named-content></addr-line>, <country>France</country></aff><aff id="aff4"><institution content-type="dept">Department of Translational Molecular Medicine</institution>, <institution>Providence Saint John's Health Center</institution>, <addr-line><named-content content-type="city">Santa Monica</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Cancer Biology and Epigenetics Group</institution>, <institution>Portuguese Oncology Institute</institution>, <addr-line><named-content content-type="city">Porto</named-content></addr-line>, <country>Portugal</country></aff><aff id="aff6"><institution content-type="dept">Department of Experimental Oncology</institution>, <institution>Instituto Europeo di Oncologia</institution>, <addr-line><named-content content-type="city">Milan</named-content></addr-line>, <country>Italy</country></aff><aff id="aff7"><institution content-type="dept">Laboratory for Functional Genomics</institution>, <institution>Fondation Jean Dausset-CEPH</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff><aff id="aff8"><institution content-type="dept">Laboratory for Epigenetics and Environment</institution>, <institution>CNRS,  CEA-Institut de Biologie François Jacob</institution>, <addr-line><named-content content-type="city">Evry</named-content></addr-line>, <country>France</country></aff><aff id="aff9"><institution content-type="dept">Department Structural Biology and Chemistry</institution>, <institution>Institut Pasteur, CNRS UMR 3523</institution>, <addr-line><named-content content-type="city">Paris</named-content></addr-line>, <country>France</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-148642"><name><surname>Robles-Espinoza</surname><given-names>C Daniela</given-names></name><role>Reviewing editor</role><aff><institution>International Laboratory for Human Genome Research</institution>, <country>Mexico</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>paola.arimondo@cnrs.fr</email> (PA);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>09</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e78587</elocation-id><history><date date-type="received"><day>11</day><month>03</month><year>2022</year></date><date date-type="accepted"><day>18</day><month>09</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Carrier et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Carrier et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78587-v1.pdf"/><abstract><p>Aberrant DNA methylation is a well‑known feature of tumours and has been associated with metastatic melanoma. However, since melanoma cells are highly heterogeneous, it has been challenging to use affected genes to predict tumour aggressiveness, metastatic evolution, and patients' outcomes. We hypothesized that common aggressive hypermethylation signatures should emerge early in tumorigenesis and should be shared in aggressive cells, independent of the physiological context under which this trait arises. We compared paired melanoma cell lines with the following properties: <italic>(i)</italic> each pair comprises one aggressive counterpart and its parental cell line, and <italic>(ii)</italic> the aggressive cell lines were each obtained from different host and their environment (human, rat, and mouse), though starting from the same parent cell line. Next, we developed a multi-step genomic pipeline that combines the DNA methylome profile with a chromosome cluster-oriented analysis. A total of 229 differentially hypermethylated genes were commonly found in the aggressive cell lines. Genome localization analysis revealed hypermethylation peaks and clusters, identifying eight hypermethylated gene promoters for validation in tissues from melanoma patients. Five CpG identified in primary melanoma tissues were transformed into a DNA methylation score that can predict survival (Log-rank test, <italic>p</italic>=0.0008). This strategy is potentially universally applicable to other diseases involving DNA methylation alterations.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>CNRS</institution></institution-wrap></funding-source><award-id>ATIP to PBA</award-id><principal-award-recipient><name><surname>Arimondo</surname><given-names>Paola B</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>Region Midi Pyrenees-CNRS</institution></institution-wrap></funding-source><award-id>Equipe d'excellence to PBA</award-id><principal-award-recipient><name><surname>Arimondo</surname><given-names>Paola B</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Region Midi Pyrenees - CNRS</institution></institution-wrap></funding-source><award-id>FEDER to PBA</award-id><principal-award-recipient><name><surname>Arimondo</surname><given-names>Paola B</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>Fondation InnaBioSante</institution></institution-wrap></funding-source><award-id>EpAM to PBA</award-id><principal-award-recipient><name><surname>Arimondo</surname><given-names>Paola B</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution>Adelson Medical Research Foundation</institution></institution-wrap></funding-source><award-id>grant to DH and MB</award-id><principal-award-recipient><name><surname>Hoon</surname><given-names>Dave SB</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Tumour samples from melanoma patients were obtained from the tumour tissue bank at the Department of Pathology, IUCT-O Toulouse Hospital (France). The study was carried out in accordance with the institutional review board-approved protocols (CRB, AC-2013-1955) and the procedures followed were in accordance with the Helsinki Declaration.This study was approved by the institutional ethics committee of IPO Porto (CES-IPOP-FG13/2016).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession code  GSE155856R-scripts are available in Source Code 1 fileThe datasets supporting the conclusions of this article are included within the article and the following Supplementary files</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Arimondo PB</collab></person-group><year iso-8601-date="2022">2022</year><source>DNA methylome combined with chromosome cluster-oriented analysis provides an early signature for cutaneous melanoma aggressiveness</source><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE155856">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE155856</ext-link><comment>NCBI Gene Expression Omnibus, GSE155856</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-78587-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>